What is Rigel Pharmaceuticals's net debt / EBITDA?

Rigel Pharmaceuticals (RIGL) reported net debt / EBITDA of 0.3× in Q1 2026.

How has Rigel Pharmaceuticals's net debt / EBITDA changed year-over-year?

Rigel Pharmaceuticals's net debt / EBITDA increased by 136.0% year-over-year, from -1× to 0.3×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Rigel Pharmaceuticals RIGL Net debt / EBITDA

Net debt / EBITDA at other companies

AmgenAMGN

3.7×-0.7×

Zevra Therapeutics, Inc.ZVRA

-35.8×—

Gyre Therapeutics, Inc.GYRE

-14.8×-16.1×

Eton Pharmaceuticals, Inc.ETON

7.6×—

Theravance BiopharmaTBPH

-84.1×—

XER

Xeris Biopharma Holdings, Inc.XERS

3.9×—

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

net debt/ebitda=0.3×

Based on the most recent quarter.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's net debt / EBITDA?: Rigel Pharmaceuticals (RIGL) reported net debt / EBITDA of 0.3× in Q1 2026.
How has Rigel Pharmaceuticals's net debt / EBITDA changed year-over-year?: Rigel Pharmaceuticals's net debt / EBITDA increased by 136.0% year-over-year, from -1× to 0.3×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.